The stock of Constellium SE (CSTM) has seen a -1.13% decrease in the past week, with a 7.44% gain in the past month, and a -19.98% decrease in the past quarter. The volatility ratio for the week is 2.39%, and the volatility levels for the past 30 days are at 2.65% for CSTM. The simple moving average for the last 20 days is 1.59% for CSTM’s stock, with a simple moving average of -14.62% for the last 200 days.
Is It Worth Investing in Constellium SE (NYSE: CSTM) Right Now?
The price-to-earnings ratio for Constellium SE (NYSE: CSTM) is above average at 14.00x, Company’s 36-month beta value is 1.94.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CSTM is 132.07M, and currently, short sellers hold a 2.64% ratio of that floaft. The average trading volume of CSTM on September 05, 2024 was 1.19M shares.
CSTM) stock’s latest price update
Constellium SE (NYSE: CSTM)’s stock price has gone rise by 2.72 in comparison to its previous close of 15.93, however, the company has experienced a -1.13% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-07-25 that PARIS, July 25, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (“Constellium” or the “Company”) announced today that the Company has priced a private offering (the “Notes Offering”) of €300 million of euro denominated senior unsecured notes due 2032 (the “Euro Notes”) and $350 million of U.S. dollar denominated senior unsecured notes due 2032 (the “USD Notes” and together with the Euro Notes, the “Notes”).
Analysts’ Opinion of CSTM
Many brokerage firms have already submitted their reports for CSTM stocks, with UBS repeating the rating for CSTM by listing it as a “Buy.” The predicted price for CSTM in the upcoming period, according to UBS is $27 based on the research report published on January 16, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see CSTM reach a price target of $24. The rating they have provided for CSTM stocks is “Overweight” according to the report published on May 08th, 2023.
JP Morgan gave a rating of “Neutral” to CSTM, setting the target price at $21 in the report published on December 10th of the previous year.
CSTM Trading at -5.77% from the 50-Day Moving Average
After a stumble in the market that brought CSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.47% of loss for the given period.
Volatility was left at 2.65%, however, over the last 30 days, the volatility rate increased by 2.39%, as shares surge +7.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.73% lower at present.
During the last 5 trading sessions, CSTM fell by -1.39%, which changed the moving average for the period of 200-days by -7.54% in comparison to the 20-day moving average, which settled at $16.16. In addition, Constellium SE saw -18.02% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CSTM
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Constellium SE stands at 0.02. The total capital return value is set at 0.11. Equity return is now at value 18.56, with 3.26 for asset returns.
Based on Constellium SE (CSTM), the company’s capital structure generated 0.67 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 1.99. The interest coverage ratio of the stock is 2.76.
Currently, EBITDA for the company is 642.55 million with net debt to EBITDA at 2.52. When we switch over and look at the enterprise to sales, we see a ratio of 0.56. The receivables turnover for the company is 9.86for trailing twelve months and the total asset turnover is 1.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.33.
Conclusion
In a nutshell, Constellium SE (CSTM) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
